Theranica’s Nerivio wearable migraine therapy is now covered by health [...]

Messenger RNA (mRNA) technology could offer a new approach to [...]

ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Alamar Biosciences has launched what it describes as the first [...]

Genespire and researchers at the San Raffaele Telethon Institute for [...]

FORE Biotherapeutics has completed target enrolment in the primary central [...]

Compass Pathways has reported positive six-month results from its second [...]

EnteroBiotix has dosed the first patient in its Phase 2b [...]

Ananda Pharma has begun participant screening for a Phase 2 [...]